Compass Wealth Management LLC bought a new position in HCA Healthcare, Inc. (NYSE:HCA – Free Report) during the 2nd quarter, Holdings Channel reports. The institutional investor bought 11,026 shares of the company’s stock, valued at approximately $4,299,000.
A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Palisade Asset Management LLC bought a new position in HCA Healthcare in the third quarter valued at $26,000. MidFirst Bank purchased a new stake in shares of HCA Healthcare during the second quarter valued at approximately $28,000. Clearstead Trust LLC purchased a new position in shares of HCA Healthcare in the second quarter valued at about $29,000. Ares Financial Consulting LLC purchased a new position in HCA Healthcare during the 4th quarter valued at about $31,000. Finally, Cedar Mountain Advisors LLC bought a new position in shares of HCA Healthcare during the first quarter valued at approximately $33,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.
HCA Healthcare Stock Up 1.8%
NYSE:HCA opened at $412.27 on Wednesday. HCA Healthcare, Inc. has a 52 week low of $353.99 and a 52 week high of $556.52. The stock has a market cap of $89.26 billion, a PE ratio of 13.80, a P/E/G ratio of 1.40 and a beta of 1.10. The business’s 50-day simple moving average is $395.07 and its two-hundred day simple moving average is $445.35.
HCA Healthcare Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be issued a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio is presently 10.45%.
Analysts Set New Price Targets
HCA has been the topic of several research analyst reports. Wells Fargo & Company boosted their price target on shares of HCA Healthcare from $369.00 to $381.00 and gave the company an “equal weight” rating in a research report on Monday, August 3rd. Morgan Stanley dropped their target price on shares of HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating on the stock in a research note on Monday, July 27th. KeyCorp reduced their price objective on HCA Healthcare from $475.00 to $435.00 and set an “overweight” rating for the company in a report on Monday, July 27th. Weiss Ratings downgraded shares of HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, June 9th. Finally, Leerink Partners reduced their price target on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a research report on Monday, April 27th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $465.59.
View Our Latest Report on HCA Healthcare
HCA Healthcare Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Read More
- Five stocks we like better than HCA Healthcare
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
